Results from Three Phase 1 Trials of NNC9204-1177, a Glucagon/glp-1 Receptor Co-Agonist: Effects on Weight Loss and Safety in Adults with Overweight or Obesity.
Molecular Metabolism（2023）
Key words
Glucagon-like peptide-1,Glucose-dependent insulinotropic polypeptide,Obesity,NN1177
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined